|
INSIG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.08559999999025E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.54986999999496E-05 |
| Normal-vs-Stage2 |
3.60120000000297E-05 |
| Normal-vs-Stage3 |
2.23749999994638E-06 |
| Normal-vs-Stage4 |
4.768400E-04 |
| Stage1-vs-Stage2 |
6.662600E-01 |
| Stage1-vs-Stage3 |
3.666200E-01 |
| Stage1-vs-Stage4 |
4.174800E-01 |
| Stage2-vs-Stage3 |
2.244800E-01 |
| Stage2-vs-Stage4 |
5.951800E-01 |
| Stage3-vs-Stage4 |
2.234200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.39359999999467E-05 |
| Normal-vs-AfricanAmerican |
3.713999999988E-06 |
| Normal-vs-Asian |
5.94019999999862E-05 |
| Caucasian-vs-AfricanAmerican |
1.434790E-01 |
| Caucasian-vs-Asian |
2.622600E-01 |
| AfricanAmerican-vs-Asian |
3.446400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72350999999571E-05 |
| Normal-vs-Female |
1.009670E-04 |
| Male-vs-Female |
1.575190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.90140000003269E-06 |
| Normal-vs-Extreme_Weight |
5.81309999999613E-05 |
| Normal-vs-Obese |
1.7492799999963E-05 |
| Normal-vs-Extreme_Obese |
2.00929999999433E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.437410E-01 |
| Normal_Weight-vs-Obese |
3.283800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.994200E-01 |
| Extreme_Weight-vs-Obese |
4.203000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.604400E-01 |
| Obese-vs-Extreme_Obese |
2.917000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.94409999998424E-06 |
| Normal-vs-Age(41-60Yrs) |
3.55320000000603E-05 |
| Normal-vs-Age(61-80Yrs) |
1.85195999999888E-05 |
| Normal-vs-Age(81-100Yrs) |
2.35459999999854E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.407500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.619160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.718600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.163200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.102200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.516000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.67991999999728E-05 |
| Normal-VS-Type2 PRCC |
3.88289999997404E-06 |
| Normal-VS-KIRP CIMP |
6.206300E-04 |
| Normal-VS-Unclassified PRCC |
1.206450E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.672800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.174600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.525200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.329000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.170210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.034400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.14440000054917E-07 |
| Normal-vs-N1 |
4.1944000000016E-05 |
| Normal-vs-N2 |
9.440200E-02 |
| N0-vs-N1 |
8.802200E-02 |
| N0-vs-N2 |
3.761200E-01 |
| N1-vs-N2 |
9.712000E-01 |
|
|
